Danaher (DHR)
(Delayed Data from NYSE)
$265.80 USD
+0.96 (0.36%)
Updated May 17, 2024 04:00 PM ET
After-Market: $265.32 -0.48 (-0.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Danaher Corporation [DHR]
Reports for Purchase
Showing records 61 - 80 ( 498 total )
Company: Danaher Corporation
Industry: Diversified Operations
GLP-1 Market Opportunity Update, 2028 Consensus Estimates +11% vs. April Report
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Lowering FY23 from HSD to MSD Despite Impressive 1Q23; Our LT View Unchanged
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
1Q23 Includes Lower Guide, but Bioprocess Remains LT Growth Driver
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Obesity/Diabetes Therapeutics, Far Surpassing Estimates
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 3123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 22123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 21123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Who''s the Biggest Shark of All? Life Science M&A Likely to Resume in 2023
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 2123
Provider: Stock Traders Daily
Analyst: Research Department